Impact of body mass index on treatment outcome of neoadjuvant chemoradiotherapy in locally advanced rectal cancer
European Journal of Surgical Oncology Sep 04, 2017
Sun Y, et al. – This study aimed at assessing the effect of obesity, measured by body mass index (BMI), on tumor response, surgical outcome in patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiotherapy (nCRT) and radical surgery. As per findings, obesity appeared associated with poorer T downstaging and Rectal Cancer Regression Grade, and thus poor local control in LARC following nCRT in Asian patients. This suggested the necessity for more effective treatment strategies to improve treatment outcome for obese patients with LARC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries